Dr. Banerjee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Summary
- Dr. Rahul Banerjee, MD, FACP, (Twitter/X: @RahulBanerjeeMD) is an Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington in Seattle, WA. His clinical interests are in multiple myeloma and CAR-T therapy. He is a member of the International Myeloma Working Group and has published over 70 peer-reviewed publications with an emphasis on improving the experiences of patients as they undergo treatment for multiple myeloma.
Education & Training
- University of California San FranciscoAdvanced Fellowship, BMT/CAR-T Therapy, 2021 - 2022
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2018 - 2021
- University of Pennsylvania Health SystemChief Residency, Internal Medicine, 2017 - 2018
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2017
- University of Pennsylvania Health SystemInternship, Internal Medicine, 2014 - 2015
- The Warren Alpert Medical School of Brown UniversityClass of 2014, MD, AOA Inductee
Certifications & Licensure
- CA State Medical License 2018 - 2026
- WA State Medical License 2022 - 2025
- PA State Medical License 2014 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Winner, Department of Medicine ‘Shelter-in-Poetry’ Competition University of California San Francisco, 2020
- Penn Pearls Award Recipient Perelman School of Medicine, University of Pennsylvania, 2017
- Samaha Award for resident scholarship Penn Medicine, 2017
- Join now to see all
Clinical Trials
- Digital Life Coaching for Myeloma Patients Undergoing Transplantation Start of enrollment: 2020 May 20
- Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing Transplantation Start of enrollment: 2020 Dec 29
- Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma With Isatuximab Start of enrollment: 2022 Jun 17
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsDriving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors.Rahul Banerjee, Jean C. Yi, Navneet S. Majhail, Heather S.L. Jim, Joseph P. Uberti
Biology of Blood and Marrow Transplantation. 2020-11-01 - 16 citationsNext-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health.Rahul Banerjee, Nina Shah, Adam P. Dicker
JCO Clinical Cancer Informatics. 2021-06-10 - 11 citationsSafety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma.Kevin R Reyes, Chiung-Yu Huang, Mimi Lo, Shagun Arora, Alfred Chung
Transplantation and Cellular Therapy. 2023-06-01
Journal Articles
- IlliteracyBanerjee R, The Pharos of Alpha Omega Alpha Honor Medical Society, 2/21/2017
Books/Book Chapters
Press Mentions
- J&J, Legend Solidify Carvykti's Lead in Earlier Multiple Myeloma with Strong Survival ShowingSeptember 30th, 2024
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis showsSeptember 13th, 2024
- Conquer Cancer-Funded Research Helps a Patient Reconnect With the Hobbies He LovesSeptember 4th, 2024
- Join now to see all
Grant Support
- Young Investigator AwardASCO Conquer Cancer Foundation2020–2022
Professional Memberships
- Member
- Member
- Member
- Member
- American Society for Transplantation and Cellular TherapyMember
- Member
Other Languages
- Hindi, Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: